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Abstract
microRNAs (miRNAs) repress target genes by destabilizing mRNAs and/or by inhibiting translation. The best known factor
for target recognition is the so called seed – a short continuous region of Watson-Crick base pairing between nucleotides 2–
7 of the miRNA and complementary sequences in 39 untranslated regions of target mRNAs. The miR-34 family consists of
three conserved members with important tumor suppressor functions linked to the p53 pathway. The family members
share the same seed, raising the question if they also have the same targets. Here, we analyse the effect of miR-34a and miR-
34c on protein synthesis by pSILAC. Despite significant overlap, we observe that the impact of both family members on
protein synthesis differs. The ability to identify specific targets of a family member is complicated by the occurrence of *
strand mediated repression. Transfection of miR-34 chimeras indicates that the 39end of the miRNA might be responsible for
differential regulation in case of targets without a perfect seed site. Pathway analysis of regulated proteins indicates
overlapping functions related to cell cycle and the p53 pathway and preferential targeting of several anti-apoptotic proteins
by miR-34a. We used luciferase assays to confirm that Vcl and Fkbp8, an important anti-apoptotic protein, are specifically
repressed by miR-34a. In summary, we find that miR-34a and miR-34c down-regulate distinct subsets of targets which might
mediate different cellular outcomes. Our data provides a rich resource of miR-34 targets that might be relevant for clinical
trials that want to implement the miR-34 family in cancer therapy.
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Introduction
Animal microRNAs (miRNAs) are a class of small endogenous,
non-coding RNAs mediating posttranscriptional gene silencing
[1,2]. miRNAs have a widespread impact on regulation of gene
expression and evolution and are thought to affect over 50% of all
human genes [2,3,4,5]. Their function is not restricted to normal
organism development: miRNAs also play a vital role in diseases
such as cancer, where they can act as oncogenes or tumor
suppressors [6,7].
miRNAs are transcribed as longer hairpin molecules that are
processed over several steps until they are cut by DICER into
duplexes of their final 22–23nt length [8]. As a last step, one strand
of the miRNA duplex (‘‘mature strand’’) is incorporated into the
RNA-induced silencing complex (RISC) while the other, so called
star (*) strand is supposedly degraded [9]. Once integrated into the
RISC miRNAs repress target mRNAs via either direct mRNA
cleavage or translational regulation associated with mRNA
degradation [2,10,11]. The overall role of mRNA degradation
and translational repression for miRNA-mediated regulation is not
entirely clear.
One of the most important questions is how miRNAs recognize
their target mRNAs. The best understood factor for target
recognition are so-called ‘‘seed’’ sites: stretches of perfect
Watson-Crick base pairing between nucleotide 2–7 of the miRNA
and complementary sequences in the 39 untranslated region
(39UTR) of target mRNAs. The correlation between target
repression and 39UTR seeds had been found early in the
exploration of miRNAs [12,13]. While the seed is generally
considered to be the most important sequence feature for target
recognition, it is important to note that it is neither necessary nor
sufficient. For example, some miRNA targets are down-regulated
despite missing a complete seed match [14]. Others are dependent
on so called ‘‘centered’’ seeds spanning miRNA nucleotides 4 to 15
[15]. Finally, many mRNAs which contain a 39UTR seed match
are not repressed by over-expression of the corresponding
miRNA. Collectively, these observations indicate that the seed is
not the only factor involved in target recognition.
Since members of miRNAs families usually share the same seed
site but differ in their remaining sequence they present a natural
setup to study target selection independent of seed differences
[16,17]. Differential targeting of family members should be
mediated by variations aside the seed site and be more
physiological than artificial mutations of miRNAs. In fact, it has
been proposed that miRNA families do have different targets
depending on their 39end sequence [14]. However, only few
studies investigated target selection of miRNA families by over-
expression of individual family members so far. Two microarray
studies on the miR-16 and miR-34 families came to the conclusion
that members of both families show functional redundancy
[18,19]. The miR-34 family is a particularly interesting example
as one of the few families that are also conserved in Drosophila and
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C. elegans [20]. While invertebrates only possess one miR-34 gene,
the miR-34 family consists of three members in vertebrates
encoded at two different gene loci [21,22]. While miR-34a and
miR-34c are perfectly conserved in sequence between human,
mouse and chicken, miR-34b shows slight nucleotide alterations
between the three species [23].
The miR-34 family is part of the p53 stress and DNA damage
response pathway and has widespread regulatory effects on the cell
[24]. Activation of p53 by genotoxic stress activates expression of
miR-34 family members [19,23]. In turn, miR-34a has been
shown to up-regulate p53 activity via a positive feedback loop
involving Sirtuin 1 leading to apoptosis [25]. Several targets of the
miR-34 family mediate cell progression and block apoptosis,
suggesting that by repressing these targets miR-34 acts as a tumor
suppressor [22,24,26,27,28,29]. Validated targets include Cdk4,
Cdk6, Hmga2, c-Met and Akt. Most of these targets have been
validated for miR-34a while the two other family members are less
well studied. Interestingly, despite the obvious links between the
miR34 family and p53, recent in vivo studies showed that mice
lacking all family members have normal p53-dependent responses
[30,31]. Ectopic expression of miR-34 within mouse tumor
models, however, can significantly reduce tumor growth in mice
and treatment with miR-34 is currently even considered for
clinical trials [32].
Whether different members of the miR-34 family have different
targets is still an open question. Despite the fact that differential
targeting between the miR-34 members has been reported, recent
reviews of the miR-34 family come to the conclusion that they are
redundant in function [27,28]. However, so far studies mainly
focused only on mRNA levels or individual selected targets. These
approaches cannot cover the effect of differential targeting miRNA
family members at the protein level on a global scale. Studies have
shown that the degree of translational repression by miRNAs can
amount to a large part of regulation [3,11]. In fact, some specific
targets of the miR-34 family such as c-Myc have been shown to be
only translationally repressed [33]. Therefore, differences between
family members may only become apparent at the protein level.
We developed pulsed stable isotope labeling by amino acids in
cell culture (pSILAC) to quantify relative changes in protein
synthesis on a global scale [3,34]. pSILAC has since been applied
to assess translational regulation in several examples, including
regulation by miR-34a [29,35]. Here, we combine pSILAC and
mRNA quantification by microarray to assess the effect of miR-
34a and miR-34c on gene expression in HeLa cells. We focused on
these two members since they show the biggest differences in
sequence and conserved from chicken to human while miR-34b
shows some sequence divergence between these species [23]. In
addition, we also generated artificial chimeras between miR-34a
and miR-34c to assess if target specificity depends on the 59 or 39
end. While we found considerable overlap, our results also indicate
that both family members target distinct subsets of genes,
suggesting non-redundant cellular functions.
Materials and Methods
miRNA design
Fully complement siRNA duplexes for miR-34 members and
chimeras were purchased from Dharmacon in annealed, desalted
and 29-deprotected form for direct use. Full complement duplexes
were designed as follows (sense and antisense 59-39):
miR-34a: UGGCAGUGUCUUAGCUGGUUGU/ AAC-
CAGCUAAGACACUGCCAUA
miR-34c: AGGCAGUGUAGUUAGCUGAUUGC/ AAU-
CAGCUAACUACACUGCCUGG
miR-34ac: UGGCAGUGUAGUUAGCUGAUUGC/ AAU-
CAGCUAACUACACUGCCAUA
miR-34ca: AGGCAGUGUCUUAGCUGGUUGU/ AAC-
CAGCUAAGACACUGCCUGG
Cell culture and Transfection of HeLa cells with
double-stranded RNAs
HeLa (LGC Promochem) cells for mass spectrometry experi-
ments were grown at 37uC with 5% CO2 in Dulbecco’s Modified
Eagle’s Medium (DMEM) High Glucose (4.5 g/l) (PAA, custom
preparation) supplemented with 10% sterile-filtered dialyzed fetal
bovine serum (dFBS, Sigma-Aldrich), 4 mM stable Glutamine (l-
alanyl-l-glutamine, PAA), light L-arginine (84 mg/l) and L-lysine
(40 mg/l) [36]. The cells were transfected and processed as
described before [3]. In short, transfection of synthetic RNAs
(Dharmacon) of a final concentration of 100 nM was done
according to the manufacturers protocol using DharmaFECT1
(Dharmacon). For transfection HeLa cells were plated on 10 cm
dishes in antibiotic-free light (L) SILAC medium at a confluence of
,70–80%. A mock control transfected with ddH2O instead of
RNA was prepared for each RNA transfected sample. 8h after
transfection, cells were washed twice and the medium for RNA
transfected samples was changed to medium-heavy (M) SILAC
medium (84 mg/l 13C6-L-arginine and 40 mg/L
2H4-L-lysine),
while mock transfections were transferred to heavy (H) SILAC
medium (84 mg/l 13C6
15N4-L-arginine and 40 mg/l
13C6
15N2-L-
lysine). 24h after pulse labeling cells were scraped off the plates,
combined with the matching control, lysed using RIPA buffer and
subjected to one-dimensional SDS-PAGE as described below. In
addition to the original miR-34a and miR-34c transfection
experiment, two replicates of miR-34a and one replicate of miR-
34c were done in an independent transfection as were the miR-34
chimera RNA transfections.
Determination of transfection efficiency
To ensure delivery of our synthetic siRNA duplexes we did
transfections of double stranded, fluorescently labeled RNA
oligomers (‘‘BLOCK-IT’’, Invitrogen) prior to further transfection
experiments. The oligomers were transfected as described above.
8h after transfection cells were washed with 1x PBS (Gibco) and
fixated in 4% paraformaldehyde (PFA) in D-PBS. Transfection
efficiency was compared via the fluorescence of transfected versus
non-transfected cells on a fluorescence microscopy (Keyence
Biozero).
SDS-PAGE and tryptic digestion of samples
About 100 mg of mixed protein samples were loaded on a 4–
12% NuPageTM Bis-Tris gradient gels (Invitrogen) and separated
according to the manufacturer’s instructions. Gels were subjected
to fixative solutions and colloidal Coomassie Brilliant Blue G-250
(Invitrogen) and single protein lanes were subsequently cut into
12-15 slices. Destaining, washing and tryptic digestion was done as
described before [37]. Before mass spectrometry samples were
extracted and desalted using StageTips [38].
LC-MS/MS measurement
LC – MS/MS analysis was performed as described before [3].
Peptides were analyzed using online reversed-phase liquid
chromatography (rpHPLC) connected to an electrospray ion
source (Proxeon) of a LTQ-Orbitrap mass spectrometer. rpHPLC
was done using either the Agilent HPLC 1200 or Eksigent
NanoLC – 1D Plus system. miR-34a and miR-34c samples were
measured on Orbitrap classic and XL instruments while the
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chimera samples (miR-34ac and miR-34ca) were analysed on an
Orbitrap Velos (Thermo Fisher). For HPLC separation we used
fritless C18 microcolumns (75 m ID packed with ReproSil-Pur
C18-AQ 3-mm resin, Dr. Maisch GmbH), manually produced as
describe before [39]. Peptide were loaded onto the column using a
flow rate of 500 nl/min (Agilent HPLC 1200) or 250 nl/min
(Eksigent/Proxeon HPLC). Gradients were run and subsequently
eluted with a flow rate of 200 nl/min with a 10 to 60 %
acetonitrile gradient of 155min or 240min in 0.5% acetic acid.
The Orbitraps were operated in a top5 or 10 mode using data
dependent acquisition of MS/MS scans as essentially described
before [40]. In this mode, every full MS scan in the Orbitrap (m/z
300–1700; resolution 60,000; target value 16106) is followed up by
5 or 10 consecutive MS/MS scans in the LTQ isolating and
fragmenting the 5 or 10 top most intense ions (charge . 1; target
value 5000; monoisotopic precursor selection enabled) by collision
induced dissociation (CID; 35% normalized collision energy and
wideband activation enabled). Dynamic exclusion of 60sec was
used to minimize repeated fragmentation of the same ions.
Processing of MS data
Mass spectrometry data were processed using the MaxQuant
software version 1.0.13.13 [41] using the MASCOT search engine
(version 2.2, MatrixScience). To facilitate data integration all raw
files were processed together. Labels were set to medium-heavy
(Arg6 and Lys4) and heavy (Arg10 and Lys8) with a maximum of
three labeled amino acids per peptide (top 6 MS/MS peaks per
100 Da; Quant.exe). The resulting peak lists were submitted to the
MASCOT engine and searched for matches with an in-house
curated concatenated target-decoy database consisting forward
and reversed proteins (supplemented with a fasta file for
identification of common contaminants). Version 3.64 of the
human IPI database (84,054 entries) was used for our analysis.
Tryptic specificity with a maximum of two missed cleavages was
required. The mass tolerance was set to 0.5 Da for fragment ions.
For precursor ions, individual mass tolerances were assigned by
MaxQuant as described [41]. Accepting thresholds for individual
spectra were defined based on the target decoy database search
strategy implemented in the MaxQuant software. Variable
modifications were set to oxidation of methionine and acetylation
of the protein N-terminus, while carbamidomethylation of cysteine
was selected as fixed modification. For protein assembly only
peptides with a minimum length of 6 amino acids were considered
and per protein group at least one peptide was required. A
maximum false discovery rate (FDR) of 1% (peptide and protein
level) was allowed which was calculated by matches to reversed
sequences in the concatenated target-decoy database. Only unique
and ‘‘razor’’ peptides (non-unique peptides of to the protein group
with the highest number of peptides) with a minimum ratio count
of two were used for protein quantification. Normalization of data
was done by MaxQuant under the assumption that most protein
ratios do not change upon miRNA transfection. After removal of
reverse hit and contaminants, we matched Reseq NP identifier of
the MaxQuant output table with a list of Refseq NM IDs
containing the number of mature or *seed sites in the 39UTR of
the respective gene. This list was curated using a list of human
gene 39UTR sequences downloaded from the UCSC Genome
Browser (http://genome.ucsc.edu, gene list update from February
2009). This list of 39UTRs was also the basis for all further studies
(Sylarray, Sequence motifs analyses). The script also mapped
PicTar (http://pictar.bio.nyu.edu/cgibin/new_PicTar_mouse.cgi)
predictions for all miR-34 members to our protein data. As a last
step, log2 fold changes were calculated from the normalized H/M
ratios of each sample. The resulting table was merged with the
microarray data.
Luciferase cloning and assays
The 39UTRs of Fkbp8 (NM_012181) and Prkar2a
(NM_004157) were synthesized and cloned into the pRL-TK
Cxcr4 vector with prior removal of the Cxcr4 4x target site by
Not1/Xho1 digestion and verified by sequencing (SINA Science
Services GmbH). The Vcl (NM_014000) vector was a kind gift of
Dr. Markus Kaller cloned into the pGL3-control-MCS vector
[29]. As positive control we used the known target of miR-34a
c-Met (NM_000245) from previous studies of our laboratory [3].
The sequence of the Fkbp8 39UTR without poly-A signal used
for cloning is:
59CCACCTAGGTGGCTGCCACCCCCTCTGCACACCAT-
GGACCCTGCCCTGCGCTCCCCAACTCCCCCAGGCTC-
CCTGTCCACTGCCCTCCCTGGTCTGGCCCCCTCCTCC-
GGGTTAGGGGAGCAAGGATTGGGGGTCGTGCAGCCC-
AGCCAGCAGGAGGGACTGAGGCCCTCTAGGAGGAAA-
GCCCAGAGGGAGGGGGCCCTCATTCCTTCAGACCCA-
GTTTTCCCCCACCCTCCTTACCCCGCTGGGCTAGGTC-
TCCGCCAGGGCTGGCCTCAGTTTCTCCTCAACAGGCC-
TGGGGGCAGCCCTTCCCCTGCCTAGTCCCCGCCTGA-
GTGCCAGCCCCCCACCCCGCCTGCCGCCCCCTGTCC-
AGGTTCCCTCCCCGCCACAGTGAAATAAAGCATCCCA-
CCCTGCAGTTTC3
The sequence of the Prkar2a 39UTR without poly-A signal used
for cloning is:
59GTGTGCCACACCCCAGAGCCTTCTTAGTGTGACA-
CCAAAACCTTCTGGTCAGCCACAGAACACATACAGAA-
AACAGACATGACAGAACTGTTCCTGCCGTTGCCGCCA-
CTGCTGCCATTGCTGTGGTTATGGGCATTTAGAAAAC-
TTGAAAGTCAGCACTAAAGGATGGGCAGAGGTTCAAC-
CCACACCTCCACTTTGCTTCTGAAGGCCCATTCATTAG-
ACCACTTGTAAAGATTACTCCAACCCAGTTTTTATAT-
CTTTGGTTCAAAACGGCATGTCTCTCCAACAATTTAA-
GTGCCTGATACAAAGTCCAAAGTATAAACATGCTCCT-
TTCCTCTCTTGCTGCTACTCTTGCTTTTGGAAGTTAC-
CACAGGGTCTGCAGAAACCTGTTGTATAACTGTAGAC-
ACTCTCTAATGGTTCTCAAAGGAGGAAATGTAGCCTT-
CAGTCTCCTCATTTGTCCTTTGAGGAAGTCCACATTT-
GTTCACAGTTGCAGCCTTTGGTTTTACAGTGGGAAAT-
GGTGGTGGATGATATGGACATATGTAGCCCAGTGGC-
ATTGTACTTTCTGCTGACAGCTGCACACATTACAGCT-
GTCTCCAAACCCACAGTGATGCTTAGGGAAAGACCCT-
GCTCAGGACCCAGCAGGTCAGCACCCCAGAGCAGAC-
TGATAGGTCCGTGGGACCCATGTTAGAGCAGAAAATT-
TGGGCTCAGCACATTTTACTGTTAGTAGAGAGCCAGG-
AAACGTTTTCTGGGTTGGGGATTTTGTGGGATTTTTT-
AATTTTTTTAGTAGGTTTTGTTTAACCTCTGTGCAGT-
TTGTATGAATGAATTGCTATACATTTATAAGGAGCCA-
GGGTCTGGAGGGTTGCTATCACTTTGTCCAGCCCAA-
ATACCTTCCTGGGCAACTCCTACCATTTGTTTGCAGT-
TGCCT3
Luciferase assays were performed as described previously [3]. In
short, HeLa cells were seeded in 24-well plates in light (L) SILAC
medium (16105cells/well) the day before transfection which
guaranteed a confluence of 90% the next day. The Fkbp8 or
Prkar2a luciferase reporters were transfected into HeLa cells
together with the respective miR-34 members and the pGL3
control vector (Promega) using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. For the pGL3- Vcl
reporter we used pRL-TK as a control plasmid (Promega). For
transfection 180 ng of the reporter, 20 ng of control plasmid and
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100 nM siRNA (final concentration) diluted in serum-free DMEM
were used. All transfections were done in triplicates and each
measurement was done three times. miR-16 was used as control
miRNA that did not affect the synthesis of the examined genes as
determined by MS (data from Selbach et al., 2008). The day after
transfection the medium was changed and 48h after transfection
cells were prepared and measured using the Luciferase Reporter
assay system (Promega) according to manufacturer’s instructions.
Fluorescence was measured on a MicroLumat Plus LB 96V
luminometer (Berthold Technologies) and processed using Mikro-
Win 2000 (Mikrotek Laborsysteme GmbH). Renilla luciferase
activity of the reporter constructs was normalized using the activity
of the firefly luciferase of the pGL3 control plasmid (Promega) (or
vice versa for the Vcl reporter). Evaluation of the measurement
error was done by calculating the relative error of the three
biological replicates of the respective reporter along with its
control and adding it up according to the law of error propagation.
The relative error was used as base for computing absolute errors
of the normalized expression values. To assess the pSILAC error,
the standard deviation of two replicates of the miR-34a
transfections (miR-34a1 and miR-34a2.1) was used. Errors are
displayed as +/– two standard deviations.
Data analysis
All data analysis was done using perl or R scripts, including
spearman correlation coefficients (pairs), correlation plots, cumu-
lative distributions (ecdf) and hypergeometric tests (dhyper). Seeds
to miR-34 and * strand seeds were annotated using an in-house
perl script based on 39 UTR sequences in downloaded from the
UCSC Genome Browser (http://genome.ucsc.edu, gene list
update from February 2009). Input for ‘‘Sylarray’’ analysis
(http://www.ebi.ac.uk/enright-srv/sylarray/)[42] were Refseq
NM identifiers of one transfection experiment sorted from down-
to up-regulated together with a background of all human gene
39UTR sequences downloaded from the UCSC Genome Browser
(http://genome.ucsc.edu, gene list update from February 2009).
The options ‘‘use all available words’’ and ‘‘use non-redundant
sequences’’ were selected. For gene ontology analysis and
clustering we produced lists of Refseq NM Ids according to the
different conditions tested as input for the online David Gene
Ontology tool (http://david.abcc.ncifcrf.gov/). Refseq NM Iden-
tifiers of all proteins identified in our experiments were used as
background for enrichment calculation. Output KEGG and GO
biological process (GO_BP) terms were downloaded and only
terms with at least p , 0.05 and 3 gene counts in one of the input
datasets were used for comparison. Log2 fold changes for miR-34a
expression in SW480 were extracted from Kaller et al., 2011 and
mapped to our data via IPI identifiers using R. Mature miR-34
and *strand seeds were mapped. Proteins sorted according to the
requirement given in the respective columns are marked with
‘‘True’’ or ‘‘False’’ if they comply with the requirement. We did
not filter for * strand seeds for this analysis as this would reduce the
number of shared proteins considerably.
The significance of the differences in Spearman rank correlation
coefficients was computed using the Fisher r-to-z transformation
with an online tool (http://vassarstats.net/rdiff.html). We treated
Spearman coefficients as though they were Pearson coefficients
since this procedure is more robust with respect to Type I error
than either ignoring the non-normality and computing Pearson
coefficients or converting the Spearman coefficients to Pearson
equivalents prior to transformation [43].
Results
Experimental setup
Transfection of HeLa cells was performed using double-
stranded RNAs mimicking miR-34a and miR-34c in a pulsed
SILAC (Stable Isotope Labeling of Amino Acids in Cell Culture)
approach as described before [3,34,44]. To enable measurement
of changes due to miR-34 over-expression, it was ensured that
none of the miR-34 members is detectably expressed in HeLa cells
[45]. Double-stranded RNAs were designed as mature miR-34
mimics, 22–23nt in length and with the 39strand designed as
perfect complement to the mature 59strand. A mock transfection
control was prepared in parallel for each miR-34 transfected
sample. Cells were cultivated on light SILAC medium and
transfected with the miRNA via Dharmafect1. 8h after the
transfection, we transferred the miRNA transfected cells to
medium-heavy (‘‘M’’) and control cells onto heavy (‘‘H’’) SILAC
medium, incubated for another 24h hours and subsequently
harvested them. Differentially treated cells were combined with
the mock control and analyzed by high resolution LC-MS/MS
(FIG 1A). A transfection efficiency of over 90% in HeLa cells was
determined using fluorophore-conjugated dsRNA prior to the
experiment (FIG S1).
To control for biological and technical variability we performed
biological replicates of the miR-34a and miR-34c transfection
experiments on a different day in a completely independent
manner. In addition, one miR-34a transfection experiment was
performed twice on the same day to have a comparison of
biological replicates from both the same and different days. We
also designed two chimeras of miR-34a and miR-34c comprising
the first nine nucleotides of the 59end of either miR-34a or miR-
34c paired to the remaining 39end nucleotides of the respective
other miRNA. The two chimeras miR-34ac and miR-34ca (first
letter indicates parent 59, second parent 39 end) were processed the
same way as the miR-34 members. Sequences of all miR-34 family
members and chimeras can be seen FIG 1B.
miR-34a and miR-34c induced changes in protein
synthesis
Mass spectrometry lead to the identification of overall 6,241 and
quantification of 5,435 proteins in all experiments. We required at
least two quantified peptide evidences in each experiment,
resulting in about 2,400 to 4,800 quantified proteins in each
individual transfection experiment at a false discovery rate of 1%.
The complete set of quantified proteins is given in Table S1.
Several targets of the miR-34s described in literature were down-
regulated in our data as well (FIG 2A). Note, that we removed all
proteins that we were not able to map to a specific mRNA from all
further analysis.
Since the seed match within 39UTRs is important for miRNA
target selection, direct miR-34 targets should be enriched for 39
UTR seeds. We therefore investigated if proteins with a seed
match in their corresponding mRNAs are down-regulated at the
protein level. This can be visualized using cumulative distribution
plots of the miR-34 transfections. Here, the distribution of log2
fold changes for proteins with or without a 39UTR seed match are
plotted. ‘‘Seed proteins’’ clearly showed reduced protein synthesis
compared to non-seed proteins (FIG 2 B,C). This effect is not
observed with a seed of a different miRNA such as miR-1 (FIG.
2D). We conclude that many proteins in our pSILAC data are
directly repressed by miR-34.
Next, we sought to determine a cut-off value to define targets of
miR-34. To this end, we calculated how significant the enrichment
of proteins with 39 UTR seed matches is at different cut-offs using
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the hypergeometric test (FIG 2E). Proteins down-regulated by
miR-34a were highly significantly enriched in miR34 seeds even at
mild cut-offs (for example, p = 6610216 for proteins with log2FC
, 0). To minimize false positives we used a more stringent cut-off
of –0.3 (p = 3.8610223, dashed line). To obtain an estimate of the
actual number of direct targets identified at this cut-off we asked
how many of the down-regulated proteins can be explained by the
seed. 655 and 687 proteins had a log2FC smaller than –0.3 in the
miR-34a and miR-34c experiments, respectively. Of these down-
regulated proteins, 275 (42%) and 257 (37%) had a 39 UTR seed
match for miR-34a and c. The background seed frequency of non-
regulated proteins (absolute log2FC,0.1) was 23% in both cases.
Therefore, about 19% (miR-34a) and 14% (miR-34c) of down-
regulated proteins with a seed match are expected to be direct
targets. This amounts to 52 targets for miR-34a and 36 for miR-
34c. It should be noted that these estimates only include targets
with 39 UTR seed matches. Seed matches in the coding sequence
or targets without seed matches are not included. Thus, the true
number of direct targets is probably higher.
A nucleotide motif enrichment analysis employing the online
tool ‘‘Sylarray’’ [42] revealed that not only the signal for the
mature miRNA but also the *strand seed of the respective miR-34
member was detectable (FIG 2F,G). Recent studies suggest that
the incorporation of the *strand seed might be a common trait for
miRNAs and physiologically important [46,47,48]. However,
since the transfected RNAs were designed as perfect duplexes,
the sequence of the *strand we used in our experiments differs
from the endogenous version, most notably in the *seed region. To
minimize the impact of the artificial *seed in our data we excluded
all proteins with any of the *seed sequences in their 39UTRs. This
reduces the number of quantified proteins to 2419 in the miR-34a
and miR-34c transfection experiments (1204 proteins in all
replicates). FIG. 2H gives an overview of the regulation of proteins
by miR-34a and miR-34c. Table S1 shows all quantified proteins
and mRNA abundance for the miR-34 transfections for genes not
containing a *strand seed site in their 39UTR. Further data
analysis was done using the two miR-34 experiments and the 2419
proteins quantified unless stated otherwise.
Correlation and differences in protein regulation by
miR-34a and miR-34c
Next, we compared pSILAC data for miR-34a and miR-34c.
Log2 fold changes for both miRNAs were clearly correlated (FIG
3A, rho = 0.45). However, the scatter is higher than in typical
biological replicates with the same miRNA, suggesting that targets
of both family members are overlapping but not identical. To
assess the experimental variability in our data we performed two
parallel miR-34a experiments. Indeed, these experiments showed
considerably higher correlation (FIG 3B, rho = 0.71). Of note,
even two miR-34a experiments performed on different days
Figure 1. Experimental setup. A, Each member of the miR-34 family is transfected individually into HeLa cells in light SILAC medium. In parallel, a
mock transfected control sample is prepared for each member. After 8h of transfection the samples are transferred to different SILAC medium, heavy
(‘‘H’’) for the control and medium-heavy (‘‘M’’) for the miRNA transfected cells. After 24h of pulse labeling corresponding sample are combined and
processed for mass spectrometry. The resulting peaks for one peptide are shown as an example. Peptides produced before pulse labeling appear as
light peaks and can be disregarded. Differences in protein synthesis between control and miRNA-transfected samples can be read from the H/M ratio
of the respective peptides. B, Nucleotide sequences of the miR-34 family members miR-34a and miR-34c. To investigate the importance of 59 versus
39ends two miRNA chimeras were constructed swapping head (nt 1-9) and tail of miR-34a and miR-34c respectively. Differences in the nucleotide
sequence are marked in blue. The seed is labeled red.
doi:10.1371/journal.pone.0092166.g001
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correlated better with each other than the miR-34a and miR-34c
data derived from parallel experiments on the same day (FIG 3C).
Next, we computed whether the observed differences in Spearman
correlation coefficients are statistically significant using the Fisher
r-to-z transformation [43]. We found that the correlation between
miR-34a and miR-34c is significantly lower than the correlation
between two miR-34a replicates performed on the same day (p ,
0.0001). Even the correlation of miR-34a replicates performed on
different days is significantly better than the correlation between
miR-34a and miR-34c (p # 0.0017). This analysis strongly
suggests that the impact of both family members on protein
synthesis is not identical. Interestingly, miR-34a and miR-34c
display the biggest differences in down-regulated proteins, a hint
that they might mainly differ in their putative direct targets. In
fact, less than half of the seed proteins which are down-regulated
by miR-34a are also down-regulated by miR-34c (log2FC , –0.3,
FIG 3D). This indicates that despite the similarities between miR-
34a and miR-34c on protein regulation, each family member
down-regulates a distinct set of putative targets. To minimize the
impact of biological variability we focused our subsequent analysis
on the miR-34a and miR-34c experiments performed on the same
day.
On one hand, transfecting cells with dsRNAs mimicking mature
miRNAs is advantageous since it avoids possible differences in
miRNA processing between family members. On the other, our
artificial over-expression system might also induce unspecific
effects. We therefore compared our data with results obtained by
expressing the full precursor of miR-34a in SW480 cells [29]. In
this study, an episomal pRTS-miR-34a plasmid was induced for
16h and pSILAC labeled for 24h. Of the 1,206 quantified proteins
in this study 946 could be mapped to our HeLa dataset (of which
212 have a seed match). 81 of the shared proteins were down-
regulated in SW480 cells (log2 fold change , –0.3). Among these,
32 and 21 were down-regulated by miR-34a and miR-34c in our
HeLa data, respectively (FIG 3E). Hence, miR-34a in SW480 cells
shares more potential targets with miR-34a than with miR-34c in
HeLa cells. This observation also holds true when only proteins
with a seed match in their 39UTR are considered. The overlap for
miR-34a in both datasets is highly significant with p-values of
8.4*10215 and 5.3*10207 for non-seed and seed proteins,
respectively (hypergeometric test, FIG. 3F). For miR-34c the
overlap is less significant (p = 7.4*10205 and p= 0.009). As a
control, we also compared the overlap of our miR-34 data with
pSILAC data obtained for a different miRNA (miR-1, dataset
taken from Selbach et al., 2008). In this biologically unrelated
control the p-values exceed the significance threshold (p = 0.15,
data not shown). The fact that the overlap for miR-34a is
considerably higher than for miR-34c indicates that the observed
differences between miR-34a and miR-34c are not an artifact of
our experimental approach. Instead, the observation that our data
can be replicated in a different cell type by a different group, using
a different miRNA expression system and different pulse labeling
times strongly suggests that results are robust and meaningful
beyond our specific experimental conditions. In addition, it is in
accordance with our observation that miR-34a and miR-34c
down-regulate different sets of targets.
Pathway analysis of miR-34a and miR-34c affected
proteins
Having shown that miR-34a and miR-34c have overlapping but
not identical targets, we next asked if these differences might
reflect different biological functions. We therefore employed the
online DAVID gene ontology tool to look for enriched KEGG
pathways. Both miRNAs affected the pathways ‘‘cell cycle’’, ‘‘p53
pathway’’ and ‘‘terpenoid backbone synthesis’’ (‘‘both down’’,
FIG. 4). Hence, pathway analysis indicates functional redundan-
cies of both miRNAs. One pathway mostly enriched in miR-34a is
‘‘DNA replication’’ which includes the Mcm proteins (Mcm3/5/
6/7) and Pold1 (DNA polymerase delta catalytic subunit 1). The
miR-34a specific enrichment is also visible when only exclusive
targets of the two miRNAs are considered (miR-34a and miR-34c
exclusive, Fig. 4). Some of the involved proteins are also mildly
regulated by miR-34c which actually has been reported to regulate
‘‘DNA replication’’ as well [33]. However, in our study miR-34a
outnumbers miR-34c concerning targets in this KEGG pathway.
In addition, important genes necessary for nucleotide synthesis and
thus DNA replication such as Impdh1 are specifically repressed by
miR-34a. In summary, comparison at the level of pathways
suggests overlapping functions with a seemingly stronger impact of
miR-34a on ‘‘DNA replication’’. More details about pathway
enrichment and names of corresponding proteins are available in
Table S2.
miR-34a and miR-34c chimeras exhibit specific 5’ or
39end co-regulation of exclusive targets-
To assess sequence specificity in target selection we compared
which exclusive targets of miR-34a or miR-34c were down-
regulated in their respective 59 or 39end chimera (FIG. 5). The
exclusive targets of both miR-34 members are only partly co-
regulated by the chimera miRNAs, especially for targets without a
seed site. This is expected since genes lacking 39 UTR seeds are
more likely indirect targets. Interestingly, miR-34a and miR-34c
show different chimera preferences. For seed containing targets,
the 5’end chimera of miR-34a (mir-34ac) shows stronger and
statistically significant co-regulation of targets. miR-34c, however,
does not exhibit this effect. In addition, miR-34c has a much
smaller number of exclusive targets containing a seed site than
miR-34a. Taken together, this indicates that some of the specific
target selection of miR-34a might be due to its 5’end with the first
nucleotide being an uracil as opposed to an adenine for miR-34c.
For targets without a seed site however, a clear bias towards a co-
regulation by the 3’end chimera of miR-34c is visible. Thus for
miR-34c, this implies that base pairing with the 39end of the
miRNA governs target recognition in the absence of a seed as has
been suggested for individual examples before [14]. Importantly,
for targets without a perfect seed site the overlap with the 39 end
chimera-specific targets is highly significant for both miR-34a and
Figure 2. MiR-34a and miR-34c repress synthesis of many proteins. (A) Known targets of the miR-34 family are down-regulated in our
dataset (error bars indicate standard deviations from two or three experiments). (B) Cumulative distribution plots show that synthesis of proteins with
miR-34 seed matches in their mRNA 39UTRs is repressed by transfecting miR-34a (n = 4612). (C) The same holds true for the miR-34c transfection
(n = 4094). (D) When selecting for the seed of miR-1 this correlation between seed and down-regulation is not visible (n = 4612). (E) Enrichment of
seed matches in down-regulated proteins is significant even at mild log2FC cut-offs (hypergeometric test, dashed line: log2FC cut-off -0.3, dotted line:
significance threshold p= 0.05, n = 4612). (F) Sylarray analysis [42] of miR-34a proteins sorted from down- (left) to up-regulated (right) renders the
mature miR-34a seed (ACTGCC) as enriched nucleotide motif; however, also the *seed of our siRNA duplex (GCTGGT) is enriched in down-regulated
proteins. (G) Similar observations are made for miR-34c. (H) Overview of the numbers of quantified as well as regulated proteins in miR-34a and
miR-34c.
doi:10.1371/journal.pone.0092166.g002
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Figure 3. Proteomic comparison of miR-34a and miR-34c targets. (A) The correlation of log2 fold changes between miR-34a and miR-34c in
the same transfection experiment (n = 2419) show a lower Spearman correlation than the two replicates of miR-34a (n = 1404) (B). This holds also true
when comparing miR-34a experiments from different days (n = 1777) (C). Spearman coefficients for all proteins are marked in black, while seed
containing proteins are indicated in red. (D) The overlap of common targets between miR-34a and miR-34c is rather low. (E) The overlap of miR-34a
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miR-34c. Hence, the data from our chimera experiments is
consistent with the idea that specificity is mainly determined by the
39 end of the miRNA in the absence of a seed. If this 39end
binding requires an imperfect seed site or is sufficient for down-
regulation on its own cannot be concluded from this analysis. We
analyzed our data using RNAchimera [49] to search for sequence
motifs associated with the minimum hybridization energies of
mRNA and miR-34 members. However, no specific sequence
motif could be clearly associated with the co-regulation of 3’end or
5’end chimera regulation of exclusive targets. Nevertheless, the
fact that miR-34a and miR-34c show opposite biases for chimera
co-regulated targets clearly suggests that their sequence might be
important for a target-based distinction between both miR-34
members.
Verification of specific targets of miR-34a and miR-34c
Collectively, our results suggest that miR-34a and miR-34c have
both shared and unique targets, and that some unique targets can
only be observed at the protein level. To validate our findings we
selected three unique targets from our pSILAC dataset for
validation by luciferase assays. To create a reporter construct we
fused the full length 39 UTR of the targets Fkbp8, Vcl and Prkar2a
to the coding sequence of luciferase. We then co-transfected the
constructs with miR-34a and miR-34c and quantified protein
production by luciferase assays (FIG. 6). As a positive control we
used the 39UTR of c-MET, a known target of the miR34 family
[50,51].
In our data FK506-binding protein 8 (Fkbp8) is repressed at the
protein level in all three miR-34a experiments but unchanged in
both miR-34c experiments. Neither miR-34a nor miR-34c had a
significant impact on mRNA levels of Fkbp8 (data not shown).
Hence, Fkbp8 might be a miR-34a specific target regulated mainly
at the protein level. Fkbp8 acts as a chaperone which stabilizes the
anti-apoptotic protein Bcl-2 and thereby contributes to tumori-
genesis and chemoresistance [52,53,54]. The 39 UTR of the
Fkbp8 mRNA has a single seed match to miR-34. We found that
miR-34a but not miR-34c significantly inhibited the Fkbp8
luciferase construct (FIG. 6A). Moreover, changes quantified by
luciferase assays were overall very similar to changes quantified by
pSILAC. The same result can be seen for the miR-34 seed
containing Vinculin (Vcl), a protein important for cell structure
and adherens junctions (FIG. 6B). Both SILAC and luciferase data
show a stronger regulation of Vcl by miR-34a and a lesser or no
regulation by miR-34c. While both methods share the same
pattern, the regulation of Vcl turns out milder in the luciferase
assays for both miR-34a and miR-34c. We also assessed the
regulation of one miR-34c specific target without a seed site.
Prkar2a is the regulatory subunit of protein kinases involved in
cAMP-dependent signaling. It activates protein kinase A which in
turn phosphorylates many substrates with multiple functions in the
cell, such as sugar, glycogen and lipid metabolism. Down-
regulation of Prkar2a is associated with cell growth inhibition
and tumor suppression [55,56,57]. Our SILAC data indicate that
it is exclusively down-regulated by miR-34c. However, luciferase
assays could not replicate the down-regulation by miR-34c but
show a clear up-regulation of Prkar2a instead (FIG. 6C). This
result indicates that Prkar2a is in fact not regulated by miR-34c via
its 3’UTR and thus probably no direct target. These results
validate pSILAC data for Fkbp8 and Vcl and demonstrate that the
39 UTR is sufficient for the observed down-regulation by miR-
34a. Collectively, this suggests that both proteins are direct targets
of miR-34a but not miR-34c. The results for Prkar2a however,
suggest that some observed exclusives targets without a seed site
might not be directly regulated by miR-34c.
targets (–0.3 log2 FC) from SW480 cells [29] is bigger with miR-34a than with miR-34c targets in our HeLa dataset. Venn diagrams show the overlap of
the 81 down-regulated proteins quantified in both the Sw480 and our HeLa dataset. Numbers in Venn diagrams depict total number of proteins
down-regulated by log2 , –0.3 for one miR-34 or shared by two miR-34 members. The percentage of down regulated SW480 proteins that are also
down regulated in HeLa cells is given above the diagrams. (F) The overlap with miR-34a targets in SW480 cells is more significant for miR-34a than for
miR-34c in HeLa cells (hypergeometric test).
doi:10.1371/journal.pone.0092166.g003
Figure 4. Functional enrichment analysis of miR-34a and miR-34c. KEGG pathway enrichment for subsets of miR-34a and miR-34c targets (for
all proteins down-regulated log2, -0.3 by one member, shared by both and exclusive targets of one miR-34 member). Enrichment is depicted as the
-log of the respective p-value of the enriched term.
doi:10.1371/journal.pone.0092166.g004
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Discussion
Few microRNA families have been investigated for their
differential targeting in microarray studies before with the
conclusion of their functional redundancy [18]. However, no
large scale study of protein levels has been done up to date. Here,
we provide insights into common and differential targeting of the
miR-34 family members miR-34a and miR-34c which play a
pivotal role in tumor progression in many cancer types [23,32].
We observe that targets of both family members overlap
significantly. Thus, our proteomic data is overall consistent with
previous conclusions based on microarray experiments [18].
However, we also provide evidence suggesting that targets of both
family members are not entirely redundant: First, we observe that
the difference between pSILAC log2 fold changes induced by
miR34a and miR34c is higher than expected compared to
replicate experiments with the same miRNA. Second, we find that
miR-34a targets identified in a different cell line using a different
expression system show a higher overlap with miR-34a than with
miR-34c targets we identified. Third, pathway analysis indicates
differences in the cellular function of both family members.
Finally, luciferase assays for Fkbp8 and Vcl support that these
genes are exclusive targets of miR-34a.
It should be stressed that not all differences in the pSILAC data
result from direct effects of the transfected miRNAs. For example,
direct targets may in turn have secondary effects on protein
production. We expect that some of the observed differences are
caused by such indirect effects, even though we tried to minimize
them by performing pSILAC measurements shortly after trans-
fection. Moreover, our data is affected by technical and biological
variability. Thus, not all of the proteins that seem to be
differentially affected by both family members will be truly
differential targets. Table S1 provides pSILAC data for individual
experiments and can therefore be used as an additional reliability
filter. It is also possible that the efficiency of incorporation into the
RNA-induced silencing complex (RISC) differs between family
members. However, this is unlikely in our experimental set-up
since we used over-expression and observed overall similar
repression of the known targets Met, Cdk4 and Cdk6 at both
the protein and mRNA level.
Another concern is that over-expression of miRNAs could lead
to unspecific selection of targets that would not be repressed by
physiological concentrations of the miRNA [58,59]. However, it
has been reported that over-expression and knock-down of an
individual miRNA induces anti-correlated changes in protein
synthesis[3]. Thus, targets down-regulated by miRNA over-
expression are relieved of repression and up-regulated to a similar
extent in miRNA knock-down. If this observation also holds for
miR-34 is however not clear. Non-physiological targeting is a risk
inherent in the model of miRNA mis-expression. For example,
expression of miRNAs in cell lines and tissues outside their
physiological context might identify targets that are physiologically
irrelevant. This may also be important for miR-34 since family
members are expressed in a tissue specific manner [23]. While
miR-34a is ubiquitously expressed, miR-34b and miR-34c are of
very low abundance except for lung tissue where they outnumber
miR-34a.
Luciferase assays are one option to further validate differential
targeting and to test if repression depends on signals in 39 UTRs.
Data from luciferase assays for the seed match containing 39UTRs
of Fkbp8 and Vcl was consistent with pSILAC results, indicating
that at least some of the observed differences are indeed due to the
different family members. On the other hand, the 39 UTR of
Prkar2a lacks a seed match and is not repressed by miR-34c in the
luciferase assay, even though pSILAC suggests Prkar2a as a miR-
34c specific target. Whether this discrepancy is due to 3 9UTR
independent direct repression, indirect repression via other miR-
34c targets or measurement noise cannot be assessed at the
moment.
Base pairing between the miRNA seed and complementary
sequences in 39UTRs is generally considered to be an important
factor in target recognition, although examples of targets without a
perfect seed match also exist. We observed that down-regulated
proteins are clearly enriched for 39UTR seed matches, confirming
the importance of the seed. Interestingly, proteins with seed
matches showed a higher correlation between both miR-34a and
miR-34c than proteins without a perfect seed match. This might
suggest that differential targeting is more prominent for targets
without a perfect seed match. Alternatively, it is also possible that
Figure 5. Distribution of chimera regulation within exclusive targets for either miR-34a or miR-34c. Shown are proteins exclusively
regulated by miR-34a or miR-34c with a log2 fold change cutoff of # –0.3. Colors indicate whether these exclusives targets are also regulated by any
or both miR-34 chimeras mir-34ac and miR-34ca. The significance of the overlap between exclusive targets of the miRNAs and their chimeras was
calculated using a hypergeometric test.
doi:10.1371/journal.pone.0092166.g005
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differences in proteins lacking a seed match are due to indirect
effects. In either case, our data for Fkbp8 and Vcl implies that also
proteins with seed matches can be differentially targeted. This is in
line with the observation that c-Myc is preferentially targeted by
miR-34c [33]. Another important finding was the observation that
not only the seed of the mature miRNA but also the *strand seed
of miR-34a and miR-34c affected protein abundance in our data.
We therefore excluded proteins containing a *strand seed site in
our analysis. The *strand of endogenously expressed miRNAs can
be physiologically relevant [48,60,61]. Analysis of *strand activity
is often omitted in studies and retrospective data analysis of a
retroviral expression study of miR-34 in HCT116 cells [62]
provided evidence that the *seed was visible in the data [48].
However, in cases were miRNA mimics are designed as perfect
siRNA duplexes the observed *seed does not necessarily match the
endogenous seed. This is an important consideration for data
interpretation: The impact of the * stand limits our ability to
unambiguously identify miR-34a or miR-34c specific targets.
While we excluded all genes with perfect matches to the * strand
seed from our analysis, we cannot exclude indirect and/or seedless
targets of the artificial * strand. Thus, some of the observed
differences between miR-34a and miR-34c might in fact be
mediated by the * strand. Having said this, the highly significant
overlap with results obtained by expressing the miR-34a precursor
strongly suggests that our data is meaningful beyond our specific
experimental conditions. Further experiments to directly compare
the endogenous precursors of miR-34a and miR-34c will help
clarifying this point.
To analyze the influence of 59 and 39end differences on target
selection, we also transfected chimera miR-34s comprising a
mixture of the 59end of one with the 39end of the respective other
miR-34 member. Seed containing exclusive targets of miR-34c
Figure 6. Luciferase assays of specific miR-34a and miR-34c targets. Displayed is the relative protein production after transfection of miR-34a
and miR-34c together with vector constructs containing the 39 UTR of the two seed-containing miR-34a specific targets Fkbp8 (A) and Vcl (B) or the
seedless miR-34c specific target Prkara2a (C). The SILAC change displays the difference of log2 fold changes as observed in the proteomic data. The
known miR-34 target c-Met is used as control vector and miR-16 as control siRNA that does not significantly influence the levels of either target.
Relative protein production for Prkar2a transfected with miR-34c were higher than depicted, reaching a 191%, which is indicated by dashed lines.
P-values were calculated by one-tailed one-sample t-test from n = 3 biological replicates.
doi:10.1371/journal.pone.0092166.g006
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displayed an equal distribution of co-regulation with its 39end or
59end chimera. The higher co-regulation of exclusive miR-34a
targets by its 5’end chimera, however, suggests that the influence
of the first miRNA nucleotide might be important for the target
selection of miR-34a. Exclusive targets of both miR-34a and miR-
34c on the other hand showed a strong co-regulation with its
respective 3’end chimera, suggesting that 39end binding might
mediate this repression. This is consistent with earlier studies on
target selection of miRNA families which suggested 39end
supplementary pairing as the reason for member specific targeting
in case of an imperfect seed site [14,63]. Thus the influence of
39end complementing imperfect or absent seed sites should not be
underestimated in miRNA targeting.
Our data provides a resource for the scientific community that
might be useful to unravel the functions of the miR-34 family.
Besides cell cycle arrest and DNA damage repair, miR-34
induction via p53 can also lead to senescence and apoptosis
[28]. We observed that miR-34a down-regulates a number of anti-
apoptotic targets such as Gclm, Hspa1a and most importantly
Fkbp8. The latter directly regulates levels of Bcl-2 by acting as a
chaperone, and down-regulation of Fkbp8 leads to apoptosis
[53,54]. Fkbp8 has further functions in regulation of cell cycle
progression and cancer by triggering the degradation of Prl-3 via
the 26S proteasome [64]. miR-34c on the other hand, targets
several pro-apoptotic genes such as Pkn2, Eef1e1 and Taok1. It is
tempting to speculate that miR-34a is overall more pro-apoptosis
than miR-34c (see Fig. 7 for a hypothetical model). While further
experiments are clearly needed to address this point, it is in fact
consistent with previous reports: Apoptosis seems to depend on a
miR-34a mediated positive feedback loop that amplifies p53
activation [62,65]. miR-34a amplifies p53 levels by targeting Sirt-1
[66]. In addition, only miR-34c down-regulates c-Myc under
normal expression conditions [33]. While elevated levels of c-Myc
lead to p53 amplification and apoptosis, down-regulation inhibits
apoptosis and DNA replication followed by S-phase arrest [33].
We neither detected Sirt-1 nor c-Myc in our proteomic data.
However, our observation that the important p53 effectors Eef1e1,
Atm, Taok1 and Mapk14 are exclusively down-regulated by miR-
34c complements previous findings: Eef1e1 is the key up-stream
activator of Atm/Atr and the repression of both leads to lower p53
levels [67]. Similarly, the miR-34c levels are reduced by down-
regulation of Taok1 which phosphorylates Mapk14, a kinase that
directly regulates miR-34c levels [33,68]. It is tempting to
speculate that a main difference of the two family members is
that miR-34c dampens the initial DNA damage signal while miR-
34a amplifies it. Further functional studies are required to test this
hypothesis. Finally, the miR-34 family has recently been reported
to be also involved in neuronal and cardiovascular diseases
[69,70]. While discussing these aspects is beyond the scope of this
study, it will be interesting to see if our data also suggests functions
outside the cancer context.
Supporting Information
Figure S1 Efficiency of siRNA transfection in HeLa
cells. Fluorophore-conjugated dsRNA (‘‘BLOCK-IT’’) were
transfected into HeLa cells (a) and show a clear signalfor over
Figure 7. Hypothetical model of the differential effect of miR-34a and miR-34c on the p53 feedback network integrating both
known protein interactions with miR-34a and miR-34c and our observations. Grey color indicates proteins not quantified in our data but
with known miR-34 interactions. Color indicates down-regulation (red) and up-regulation (green) of proteins quantified in our data. miR-34a has a
positive feedback loop with p53 by blocking its inhibitor Sirt1. The effect of miR-34c on Sirt1 is not known. While miR-34a induction is heavily
dependent on p53 levels, miR-34c expression can also be induced via alternative pathways (of which Mapk14 is depicted here). c-Myc is no target of
miR-34a under normal expression conditions but is strongly repressed by miR-34c. This leads to inhibition of cell proliferation, DNA replication and
induction of S-phase arrest. c-Myc also hinders apoptosis induction under p53 activation settings.
doi:10.1371/journal.pone.0092166.g007
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90% of cells, while (b) non-transfected cells do not display
fluorescence. (For details see Material and Methods).
(TIF)
Table S1 Complete set of identified proteins.
(XLSX)
Table S2 Pathway enrichment analysis.
(XLSX)
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